Amrize AG cash flow to debt ratio of 37.39% indicates that the company generates enough cash to cover its debts. This level indicates strong financial health.

Amrize AG's free cash flow has decreased 13.41% from $1.64B last year to $1.42B, signaling decreasing performance

Amrize AG's debt to equity ratio is 0.45, which means that the company's assets are healthy financed, signaling financial stability.

Amrize AG's debt has increased relative to shareholder equity from 0.43 last year to 0.45 today, signaling weakened financials

Amrize AG has a net debt to EBITDA ratio of 1.41x, which is below the 3.00x threshold, indicating healthy leverage and financial stability

Interest expense is not separately reported in Amrize AG's latest filing, so interest coverage cannot be calculated.

Amrize AG's profit margin was 10.89% last year and is 10.03% this year, signaling decreasing performance

Amrize AG's short-term assets of $4.68B exceed its short-term liabilities of $2.86B

Amrize AG's return on assets of 4.89% is lower than the 5.00% threshold, indicating inefficient asset utilization

Amrize AG's return on equity of 8.94%, is lower than 15.00%, indicating bad performance

Amrize AG's operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation

Amrize AG has insufficient public price history to evaluate earnings stability.

Amrize AG has positive free cash flow, indicating the company generates cash after capital expenditures

Amrize AG has a free cash flow yield of 6.20%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

Amrize AG's yearly earnings has decreased 6.99% since last year from $1.27B to $1.19B, signaling decreasing performance

Amrize AG's yearly revenue has increased 0.95% since last year from $11.70B to $11.81B, signaling increasing performance

ROIC 6.83% (Source: FMP key-metrics). In the 5–10% partial-credit band. Score: 1 of 2. This band sits within the typical US weighted-average cost of capital range. Methodology choice can change the conclusion: under FMP's invested-capital definition the company is at or near its cost of capital; under narrower operating-capital definitions the same company may score higher. Invested capital here includes equity, non-current liabilities, and short-term debt. Cash is not subtracted. See methodology.

Amrize AG's 3-year revenue CAGR of 3.28% is positive, indicating growing revenue over the past 3 years

Amrize AG has insufficient public price history to evaluate revenue consistency.

Amrize AG has insufficient public price history to evaluate ROE consistency.

Amrize AG has insufficient data to evaluate this check.

Amrize AG has insufficient data to evaluate this check.

Amrize AG is overvalued relative to its fair value price of 0.00 based on Base EBITDA Valuation model

Amrize AG has an EV/EBITDA ratio of 9.52x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings

Amrize AG has insufficient data to evaluate this check.

Amrize AG has insufficient diluted EPS history to calculate the PEG ratio.

Amrize AG has negative shareholder equity; price-to-book is not meaningful and the check fails

Amrize AG has a price-to-sales ratio of 999.00x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue